BR112019000296A2 - métodos para a determinação de perfil de fragmentome de ácidos nucleicos livres de célula - Google Patents
métodos para a determinação de perfil de fragmentome de ácidos nucleicos livres de célulaInfo
- Publication number
- BR112019000296A2 BR112019000296A2 BR112019000296-0A BR112019000296A BR112019000296A2 BR 112019000296 A2 BR112019000296 A2 BR 112019000296A2 BR 112019000296 A BR112019000296 A BR 112019000296A BR 112019000296 A2 BR112019000296 A2 BR 112019000296A2
- Authority
- BR
- Brazil
- Prior art keywords
- cell free
- methods
- nucleic acid
- dna
- free nucleic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Software Systems (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662359151P | 2016-07-06 | 2016-07-06 | |
| US62/359,151 | 2016-07-06 | ||
| US201662420167P | 2016-11-10 | 2016-11-10 | |
| US62/420,167 | 2016-11-10 | ||
| US201662437172P | 2016-12-21 | 2016-12-21 | |
| US62/437,172 | 2016-12-21 | ||
| US201762489399P | 2017-04-24 | 2017-04-24 | |
| US62/489,399 | 2017-04-24 | ||
| PCT/US2017/040986 WO2018009723A1 (en) | 2016-07-06 | 2017-07-06 | Methods for fragmentome profiling of cell-free nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019000296A2 true BR112019000296A2 (pt) | 2019-04-16 |
Family
ID=60913158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019000296-0A BR112019000296A2 (pt) | 2016-07-06 | 2017-07-06 | métodos para a determinação de perfil de fragmentome de ácidos nucleicos livres de célula |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP4322168A3 (https=) |
| JP (3) | JP7448310B2 (https=) |
| KR (1) | KR102610098B1 (https=) |
| CN (1) | CN109689891B (https=) |
| AU (1) | AU2017292854B2 (https=) |
| BR (1) | BR112019000296A2 (https=) |
| CA (1) | CA3030038A1 (https=) |
| ES (1) | ES2967443T3 (https=) |
| MX (1) | MX2019000037A (https=) |
| SG (1) | SG11201811556RA (https=) |
| WO (1) | WO2018009723A1 (https=) |
Families Citing this family (130)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2572003A4 (en) | 2010-05-18 | 2016-01-13 | Natera Inc | METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| WO2012088456A2 (en) | 2010-12-22 | 2012-06-28 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| AU2011358564B9 (en) | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
| ES2625288T3 (es) | 2011-04-15 | 2017-07-19 | The Johns Hopkins University | Sistema de secuenciación segura |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| AU2013338393C1 (en) | 2012-10-29 | 2024-07-25 | The Johns Hopkins University | Papanicolaou test for ovarian and endometrial cancers |
| EP3957749A1 (en) | 2014-04-21 | 2022-02-23 | Natera, Inc. | Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
| IL305462A (en) | 2015-07-23 | 2023-10-01 | Univ Hong Kong Chinese | DNA fragmentation pattern analysis suitable clean |
| US11286531B2 (en) | 2015-08-11 | 2022-03-29 | The Johns Hopkins University | Assaying ovarian cyst fluid |
| CA3185611A1 (en) | 2016-03-25 | 2017-09-28 | Karius, Inc. | Synthetic nucleic acid spike-ins |
| WO2017181202A2 (en) | 2016-04-15 | 2017-10-19 | Natera, Inc. | Methods for lung cancer detection |
| US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| CA3046007A1 (en) | 2016-12-22 | 2018-06-28 | Guardant Health, Inc. | Methods and systems for analyzing nucleic acid molecules |
| EP4421489B1 (en) | 2017-01-25 | 2026-03-11 | The Chinese University of Hong Kong | Diagnostic applications using nucleic acid fragments |
| WO2019016353A1 (en) * | 2017-07-21 | 2019-01-24 | F. Hoffmann-La Roche Ag | CLASSIFICATION OF SOMATIC MUTATIONS FROM A HETEROGENEOUS SAMPLE |
| IL319255A (en) | 2017-08-07 | 2025-04-01 | Univ Johns Hopkins | Methods and materials for cancer assessment and treatment |
| WO2019060716A1 (en) | 2017-09-25 | 2019-03-28 | Freenome Holdings, Inc. | SAMPLE EXTRACTION METHODS AND SYSTEMS |
| JP2021506342A (ja) | 2017-12-14 | 2021-02-22 | ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． | 移植のための移植片適合性の評価 |
| WO2019147663A1 (en) * | 2018-01-24 | 2019-08-01 | Freenome Holdings, Inc. | Methods and systems for abnormality detection in the patterns of nucleic acids |
| JP7506380B2 (ja) * | 2018-02-27 | 2024-06-26 | コーネル・ユニバーシティー | 残存病変の検出システム及び方法 |
| CN112601826B (zh) | 2018-02-27 | 2025-03-11 | 康奈尔大学 | 通过全基因组整合进行循环肿瘤dna的超灵敏检测 |
| EP3762513A1 (en) | 2018-03-08 | 2021-01-13 | St. Johns University | Circulating serum cell-free dna biomarkers and methods |
| WO2019178289A1 (en) | 2018-03-13 | 2019-09-19 | Grail, Inc. | Method and system for selecting, managing, and analyzing data of high dimensionality |
| US12087406B2 (en) | 2018-03-15 | 2024-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods using chromatin-related nucleic acid signals for performing clinical actions |
| JP7455757B2 (ja) * | 2018-04-13 | 2024-03-26 | フリーノーム・ホールディングス・インコーポレイテッド | 生体試料の多検体アッセイのための機械学習実装 |
| CA3096678A1 (en) * | 2018-04-13 | 2019-10-17 | Grail, Inc. | Multi-assay prediction model for cancer detection |
| CA3090426A1 (en) | 2018-04-14 | 2019-10-17 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
| CN112888459B (zh) | 2018-06-01 | 2023-05-23 | 格里尔公司 | 卷积神经网络系统及数据分类方法 |
| WO2020006369A1 (en) * | 2018-06-29 | 2020-01-02 | Guardant Health, Inc. | Methods and systems for analysis of ctcf binding regions in cell-free dna |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| JP7637615B2 (ja) * | 2018-09-04 | 2025-02-28 | ガーダント ヘルス， インコーポレイテッド | 無細胞核酸試料におけるアレル不均衡を検出するための方法およびシステム |
| JP7654538B2 (ja) * | 2018-10-08 | 2025-04-01 | フリーノム ホールディングス，インク． | 転写因子プロファイリング |
| GB201818159D0 (en) | 2018-11-07 | 2018-12-19 | Cancer Research Tech Ltd | Enhanced detection of target dna by fragment size analysis |
| ES3059710T3 (en) | 2018-11-21 | 2026-03-23 | Karius Inc | Direct-to-library methods, systems, and compositions |
| CA3118742A1 (en) * | 2018-11-21 | 2020-05-28 | Karius, Inc. | Detection and prediction of infectious disease |
| US10468141B1 (en) * | 2018-11-28 | 2019-11-05 | Asia Genomics Pte. Ltd. | Ancestry-specific genetic risk scores |
| US11581062B2 (en) | 2018-12-10 | 2023-02-14 | Grail, Llc | Systems and methods for classifying patients with respect to multiple cancer classes |
| KR20210113237A (ko) * | 2018-12-19 | 2021-09-15 | 더 차이니즈 유니버시티 오브 홍콩 | 무 세포 dna 말단 특성 |
| WO2020132499A2 (en) * | 2018-12-21 | 2020-06-25 | Grail, Inc. | Systems and methods for using fragment lengths as a predictor of cancer |
| EP3899049A1 (en) * | 2018-12-21 | 2021-10-27 | F. Hoffmann-La Roche AG | Identification of global sequence features in whole genome sequence data from circulating nucelic acid |
| WO2020150258A1 (en) * | 2019-01-15 | 2020-07-23 | Luminist, Inc. | Methods and systems for detecting liver disease |
| MX2020014095A (es) * | 2019-01-24 | 2021-03-09 | Illumina Inc | Metodos y sistemas para monitorear la salud y enfermedad de organos. |
| EP4567131A3 (en) | 2019-01-31 | 2025-09-03 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
| US11475978B2 (en) | 2019-02-12 | 2022-10-18 | Tempus Labs, Inc. | Detection of human leukocyte antigen loss of heterozygosity |
| AU2020221847B2 (en) | 2019-02-12 | 2026-04-02 | Tempus Ai, Inc. | Detection of Human Leukocyte Antigen loss of heterozygosity |
| WO2020176659A1 (en) * | 2019-02-27 | 2020-09-03 | Guardant Health, Inc. | Methods and systems for determining the cellular origin of cell-free dna |
| CA3134519A1 (en) * | 2019-04-15 | 2020-10-22 | Natera, Inc. | Improved liquid biopsy using size selection |
| US12497662B2 (en) | 2019-04-16 | 2025-12-16 | Grail, Inc. | Systems and methods for tumor fraction estimation from small variants |
| EP4425506A3 (en) | 2019-05-22 | 2024-12-04 | Grail, Inc. | Systems and methods for determining whether a subject has a cancer condition using transfer learning |
| WO2020243722A1 (en) | 2019-05-31 | 2020-12-03 | Guardant Health, Inc. | Methods and systems for improving patient monitoring after surgery |
| EP3980559A1 (en) | 2019-06-06 | 2022-04-13 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
| EP3997242B1 (en) * | 2019-07-09 | 2026-04-08 | The Translational Genomics Research Institute | Methods of detecting disease and treatment response in cfdna |
| EP4018003A1 (en) * | 2019-08-28 | 2022-06-29 | Grail, LLC | Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids |
| CN110706749B (zh) * | 2019-09-10 | 2022-06-10 | 至本医疗科技（上海）有限公司 | 一种基于组织器官分化层次关系的癌症类型预测系统和方法 |
| US11891653B2 (en) | 2019-09-30 | 2024-02-06 | Guardant Health, Inc. | Compositions and methods for analyzing cell-free DNA in methylation partitioning assays |
| EP4041888A4 (en) | 2019-10-11 | 2023-11-01 | Guardant Health, Inc. | USE OF CELLULAR BACTERIAL NUCLEIC ACIDS FOR CANCER DETECTION |
| CA3157560A1 (en) | 2019-11-26 | 2021-06-03 | Dustin Howard HITE | Methods, compositions and systems for improving the binding of methylated polynucleotides |
| US20230028790A1 (en) * | 2019-11-29 | 2023-01-26 | GC Genome Corporation | Artificial intelligence-based chromosomal abnormality detection method |
| CN115151657A (zh) * | 2019-12-20 | 2022-10-04 | 安可济控股有限公司 | 用于疾病检测的方法和系统 |
| WO2021130356A1 (en) * | 2019-12-24 | 2021-07-01 | Vib Vzw | Disease detection in liquid biopsies |
| JP2023513606A (ja) | 2020-02-14 | 2023-03-31 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 核酸を評価するための方法および材料 |
| AU2021227920A1 (en) * | 2020-02-28 | 2022-09-08 | Grail, Llc | Systems and methods for calling variants using methylation sequencing data |
| JP7843243B2 (ja) | 2020-04-30 | 2026-04-09 | ガーダント ヘルス， インコーポレイテッド | 分配された核酸を使用した配列決定のための方法 |
| CN116018646A (zh) * | 2020-05-22 | 2023-04-25 | 阿克图尔公司 | 用于表征无细胞核酸片段的方法 |
| EP4407042A3 (en) | 2020-07-10 | 2024-09-18 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| WO2023282916A1 (en) | 2021-07-09 | 2023-01-12 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| ES3018032T3 (en) | 2020-07-30 | 2025-05-14 | Guardant Health Inc | Methods for isolating cell-free dna |
| JP2023540221A (ja) | 2020-08-25 | 2023-09-22 | ガーダント ヘルス， インコーポレイテッド | バリアントの起源を予測するための方法およびシステム |
| WO2022061080A1 (en) * | 2020-09-17 | 2022-03-24 | The Regents Of The University Of Colorado, A Body Corporate | Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions |
| US20220154285A1 (en) | 2020-09-30 | 2022-05-19 | Guardant Health, Inc. | Analysis of methylated dna comprising methylation-sensitive or methylation-dependent restrictions |
| US12234518B2 (en) | 2020-10-23 | 2025-02-25 | Guardant Health, Inc. | Compositions and methods for analyzing DNA using partitioning and base conversion |
| EP4251765A1 (en) | 2020-11-30 | 2023-10-04 | Guardant Health, Inc. | Compositions and methods for enriching methylated polynucleotides |
| CN114634982A (zh) * | 2020-12-15 | 2022-06-17 | 广州市基准医疗有限责任公司 | 一种检测多核苷酸变异的方法 |
| EP4015650A1 (en) * | 2020-12-18 | 2022-06-22 | Nipd Genetics Biotech Limited | Methods for classifying a sample into clinically relevant categories |
| EP4267757A1 (en) | 2020-12-23 | 2023-11-01 | Guardant Health, Inc. | Methods and systems for analyzing methylated polynucleotides |
| WO2022174109A1 (en) | 2021-02-12 | 2022-08-18 | Guardant Health, Inc. | Methods and compositions for detecting nucleic acid variants |
| EP4314329A1 (en) | 2021-03-25 | 2024-02-07 | Guardant Health, Inc. | Methods and compositions for quantifying immune cell dna |
| JP2024515558A (ja) * | 2021-04-08 | 2024-04-10 | デルフィ ダイアグノスティックス インコーポレイテッド | ゲノム全体のｃｆＤＮＡ断片化プロファイルを使用するがんを検出する方法 |
| WO2022248844A1 (en) * | 2021-05-24 | 2022-12-01 | University Of Essex Enterprises Limited | Method and system for identifying genomic regions with condition sensitive occupancy/positioning of nucleosomes and/or chromatin |
| KR102927037B1 (ko) * | 2021-05-28 | 2026-02-13 | 주식회사 지씨지놈 | 조직 특이적 조절 지역의 무세포 dna 분포를 이용한 인공지능 기반 암 조기진단 방법 |
| CN113838533B (zh) * | 2021-08-17 | 2024-03-12 | 福建和瑞基因科技有限公司 | 一种癌症检测模型及其构建方法和试剂盒 |
| WO2023091517A2 (en) * | 2021-11-17 | 2023-05-25 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for gene expression and tissue of origin inference from cell-free dna |
| KR102884871B1 (ko) * | 2022-01-26 | 2025-11-11 | 권창혁 | 암 판별 장치 및 암 판별 방법 |
| EP4493711A4 (en) * | 2022-03-17 | 2026-03-18 | Delfi Diagnostics Inc | CANCER SURVEILLANCE METHOD USING FRAGMENTATION PROFILES |
| CA3246524A1 (en) | 2022-04-07 | 2023-10-12 | Guardant Health, Inc. | TUMOR PRESENCE DETECTION BASED ON THE METHYLATION STATE OF ACELLULAR NUCLEIC ACID MOLECULES |
| EP4532762A1 (en) * | 2022-06-02 | 2025-04-09 | The Board Of Trustees Of The Leland Stanford Junior University | Single molecule sequencing and methylation profiling of cell-free dna |
| JP2025522763A (ja) | 2022-06-30 | 2025-07-17 | ガーダント ヘルス， インコーポレイテッド | 異常にメチル化されたｄｎａの富化 |
| US20240043935A1 (en) * | 2022-07-29 | 2024-02-08 | Centre For Novostics Limited | Epigenetics analysis of cell-free dna |
| WO2024073508A2 (en) | 2022-09-27 | 2024-04-04 | Guardant Health, Inc. | Methods and compositions for quantifying immune cell dna |
| CN116052768A (zh) * | 2022-10-08 | 2023-05-02 | 南京世和基因生物技术股份有限公司 | 恶性肺结节筛查基因标志物、筛查模型的构建方法和检测装置 |
| WO2024112643A1 (en) * | 2022-11-21 | 2024-05-30 | Foundation Medicine, Inc. | Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy |
| JP2025542261A (ja) | 2022-12-22 | 2025-12-25 | ガーダント ヘルス， インコーポレイテッド | 統合された対象および全ゲノム体細胞およびｄｎａメチル化シーケンシングワークフロー |
| EP4638781A2 (en) | 2022-12-22 | 2025-10-29 | Guardant Health, Inc. | Methods involving methylation preserving amplification with error correction |
| EP4705522A1 (en) | 2023-05-05 | 2026-03-11 | Guardant Health, Inc. | Cell-free dna blood-based test for cancer screening |
| CN116665784B (zh) * | 2023-05-31 | 2025-12-30 | 华中农业大学 | 基于cfDNA全基因组测序数据识别染色质开放区域的方法、癌症预测模型及系统 |
| WO2025019370A1 (en) * | 2023-07-14 | 2025-01-23 | Natera, Inc. | Methods for assaying circulating tumor dna |
| WO2025029475A1 (en) | 2023-07-28 | 2025-02-06 | Guardant Health, Inc. | Methods to enrich nucleotide variants by negative selection |
| WO2025038399A1 (en) | 2023-08-11 | 2025-02-20 | Guardant Health, Inc. | Methylated enrichment methods for single-molecule genetic and epigenetic sequencing |
| CN117230165A (zh) * | 2023-09-01 | 2023-12-15 | 深圳湾实验室 | 一种无创产前检测胎儿染色体拷贝数异常的优化方法 |
| WO2025064706A1 (en) | 2023-09-19 | 2025-03-27 | Guardant Health, Inc. | Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules |
| WO2025076452A1 (en) | 2023-10-06 | 2025-04-10 | Guardant Health, Inc. | Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules |
| WO2025207817A1 (en) | 2024-03-26 | 2025-10-02 | Guardant Health, Inc. | Method of determining the likelihood of a disease by combining biomarkers and imaging |
| WO2025208044A1 (en) | 2024-03-28 | 2025-10-02 | Guardant Health, Inc. | Methods for cancer detection using molecular patterns |
| WO2025205006A1 (ja) * | 2024-03-29 | 2025-10-02 | ソニーグループ株式会社 | 分析方法、クロマチン状態を分類する方法、がん検査方法、分析システム、がん又は微小残存病変の検査システムおよび分析キット |
| WO2025235889A1 (en) | 2024-05-10 | 2025-11-13 | Guardant Health, Inc. | Methods involving multiplexed pooled pcr |
| WO2025250544A1 (en) | 2024-05-31 | 2025-12-04 | Guardant Health, Inc. | Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna |
| WO2026043718A1 (en) | 2024-08-21 | 2026-02-26 | Guardant Health, Inc. | Methods to monitor patients treated with a cancer vaccine |
| WO2026073140A1 (en) | 2024-09-27 | 2026-04-02 | Guardant Health, Inc. | Framework to identify genomic regions indicative of one or more biological conditions |
| WO2026076332A1 (en) | 2024-10-03 | 2026-04-09 | Guardant Health, Inc. | Methods involving multi-modal tumor variant identification and tracking of tumor molecules |
| CN119905148B (zh) * | 2024-12-30 | 2026-02-06 | 西藏自治区农牧科学院水产科学研究所 | 一种核间等位基因表达分析方法、装置及存储介质 |
| CN120334449B (zh) * | 2025-06-20 | 2025-09-05 | 陕西右任故里茯砖茶股份有限公司 | 基于液相色谱的茯砖茶中金花菌发酵检测方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2741117A1 (en) * | 2008-10-30 | 2010-05-06 | Centre De Recherche Public De La Sante | Biomarkers for heart failure |
| CN101901345B (zh) * | 2009-05-27 | 2013-02-27 | 复旦大学 | 一种差异蛋白质组学的分类方法 |
| US11322224B2 (en) * | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2426217A1 (en) * | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| JP6161607B2 (ja) * | 2011-07-26 | 2017-07-12 | ベリナタ ヘルス インコーポレイテッド | サンプルにおける異なる異数性の有無を決定する方法 |
| ES2886508T3 (es) * | 2011-10-06 | 2021-12-20 | Sequenom Inc | Métodos y procedimientos para la evaluación no invasiva de variaciones genéticas |
| US9367663B2 (en) * | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| BR112014020211A2 (pt) * | 2012-02-16 | 2017-07-04 | Oxford Nanopore Tech Ltd | métodos para analisar uma série ordenada por tempo de medições de um polímero, para estimar a presença, ausência ou quantidade de um polímero alvo, e para determinar uma alteração em um polímero, programa de computador, e, dispositivos de análise e de diagnóstico |
| JP6411995B2 (ja) * | 2012-03-13 | 2018-10-24 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 非侵襲的出生前診断のために大量並列シークエンシング・データを分析する方法 |
| CN103374518B (zh) * | 2012-04-12 | 2018-03-27 | 维里纳塔健康公司 | 拷贝数变异的检测和分类 |
| US10497461B2 (en) * | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| GB2533006B (en) | 2012-09-04 | 2017-06-07 | Guardant Health Inc | Systems and methods to detect copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20130309666A1 (en) * | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| GB2528205B (en) * | 2013-03-15 | 2020-06-03 | Guardant Health Inc | Systems and methods to detect rare mutations and copy number variation |
| WO2014204991A1 (en) * | 2013-06-17 | 2014-12-24 | Verinata Health, Inc. | Method for determining copy number variations in sex chromosomes |
| US9499870B2 (en) * | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| ES2660989T3 (es) | 2013-12-28 | 2018-03-27 | Guardant Health, Inc. | Métodos y sistemas para detectar variantes genéticas |
| CA2950596C (en) * | 2014-05-30 | 2023-10-31 | Verinata Health, Inc. | Detecting fetal sub-chromosomal aneuploidies and copy number variations |
| CN107002122B (zh) * | 2014-07-25 | 2023-09-19 | 华盛顿大学 | 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法 |
| EP3502273B1 (en) * | 2014-12-12 | 2020-07-08 | Verinata Health, Inc. | Cell-free dna fragment |
-
2017
- 2017-07-06 KR KR1020197003420A patent/KR102610098B1/ko active Active
- 2017-07-06 ES ES17824931T patent/ES2967443T3/es active Active
- 2017-07-06 JP JP2018568937A patent/JP7448310B2/ja active Active
- 2017-07-06 MX MX2019000037A patent/MX2019000037A/es unknown
- 2017-07-06 WO PCT/US2017/040986 patent/WO2018009723A1/en not_active Ceased
- 2017-07-06 EP EP23202039.6A patent/EP4322168A3/en active Pending
- 2017-07-06 BR BR112019000296-0A patent/BR112019000296A2/pt not_active Application Discontinuation
- 2017-07-06 CN CN201780054825.3A patent/CN109689891B/zh active Active
- 2017-07-06 CA CA3030038A patent/CA3030038A1/en active Pending
- 2017-07-06 AU AU2017292854A patent/AU2017292854B2/en active Active
- 2017-07-06 EP EP17824931.4A patent/EP3481966B1/en active Active
- 2017-07-06 SG SG11201811556RA patent/SG11201811556RA/en unknown
-
2021
- 2021-10-26 JP JP2021174556A patent/JP2022025101A/ja not_active Withdrawn
-
2024
- 2024-06-05 JP JP2024091417A patent/JP2024119898A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3481966B1 (en) | 2023-11-08 |
| JP7448310B2 (ja) | 2024-03-12 |
| CA3030038A1 (en) | 2018-01-11 |
| ES2967443T3 (es) | 2024-04-30 |
| EP4322168A3 (en) | 2024-05-15 |
| CN109689891B (zh) | 2024-06-18 |
| JP2024119898A (ja) | 2024-09-03 |
| SG11201811556RA (en) | 2019-01-30 |
| JP2019531700A (ja) | 2019-11-07 |
| EP4322168A2 (en) | 2024-02-14 |
| CN109689891A (zh) | 2019-04-26 |
| KR102610098B1 (ko) | 2023-12-04 |
| KR20190026837A (ko) | 2019-03-13 |
| AU2017292854B2 (en) | 2023-08-17 |
| JP2022025101A (ja) | 2022-02-09 |
| WO2018009723A1 (en) | 2018-01-11 |
| AU2017292854A1 (en) | 2019-01-24 |
| EP3481966A4 (en) | 2019-08-07 |
| EP3481966A1 (en) | 2019-05-15 |
| MX2019000037A (es) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019000296A2 (pt) | métodos para a determinação de perfil de fragmentome de ácidos nucleicos livres de célula | |
| BR112015012375A2 (pt) | modificação e regulação de genoma à base de crispr | |
| SG10201811337XA (en) | Systems and methods for visualizing structural variation and phasing information | |
| CL2020001894A1 (es) | Editores de nucleobase que comprende proteína de unión a adn programable de ácido nucleico. (divisional solicitud 201902679) | |
| PE20181535A1 (es) | Identificacion, fabricacion y uso de neoantigeno | |
| BR112018076027A2 (pt) | método para modificar uma sequência-alvo no genoma de uma célula vegetal; método para editar uma sequência de nucleotídeos no genoma de uma célula vegetal; método para modificar simultaneamente múltiplas sequências-alvo no genoma de uma célula vegetal; método para modificar uma sequênciaalvo de dna no genoma de uma célula vegetal e modelo de modificação de polinucleotídeo | |
| MX2019009612A (es) | Metodos de elaboracion de perfiles especificos al tipo celular para identificar objetivos de farmacos. | |
| BR112013024337A2 (pt) | locus de traço transgênico complexo em uma planta, planta ou semente, método para produzir em uma planta um locus de traço transgênico complexo e construto de expressão | |
| BR112016013520A2 (pt) | Composições e métodos de uso de sistemas crispr-cas em distúrbios de repetições de nucleotídeos | |
| BR112018069638A8 (pt) | Aparato e sistemas para dissecção minimamente invasiva de tecidos | |
| BR112018072197A2 (pt) | amplificação de emparelhamento optimizado múltiplo (moma) - pcr de tempo real para avaliar o poço fetal | |
| BR112014027242A2 (pt) | arranjos de microagulha carregada na ponta para inserção transdérmica | |
| MX2017011910A (es) | Métodos, herramientas y sistemas para la evaluación, prevención, manejo y selección de tratamiento para diabetes tipo 2. | |
| BR112014020233A2 (pt) | seleção de paciente com câncer para administração de inibidores sinalizantes wnt usando status de mutação rnf43 | |
| WO2016001760A3 (en) | Determining mutation burden in circulating cell-free nucleic acid and associated risk of disease | |
| BR112017008291A2 (pt) | oligonucleotídeos para edição de dna genômico | |
| WO2016203262A3 (en) | Gene signatures predictive of metastatic disease | |
| BR112017001971A2 (pt) | ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais? | |
| WO2016130572A3 (en) | Methods of determining levels of exposure to radiation and uses thereof | |
| UY35927A (es) | ?gen restaurador rf3 de tipo s de la esterilidad masculina citoplasmática del maíz (cms), marcadores moleculares y sus usos?. | |
| MX390053B (es) | Metodos de evaluacion genomica en ganado. | |
| Ghosh et al. | Selection of genes mediating certain cancers, using a neuro-fuzzy approach | |
| Getun et al. | Functional roles of acetylated histone marks at mouse meiotic recombination hot spots | |
| BR112018016240A2 (pt) | método de sequência alvo direta que utiliza proteção da nuclease | |
| Lin et al. | The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |